Fluconazole Drug Interactions and Precautions

Introduction to Fluconazole Interactions

The American College of Clinical Pharmacology recommends monitoring for increased anticonvulsant levels when fluconazole is co-administered with carbamazepine, due to increased risk of toxicity 1, 2, 3

For patients with renal impairment, the National Kidney Foundation suggests reducing fluconazole maintenance dose by 50% after loading dose for CrCl ≤50 mL/min 4, 5
Hemodialysis removes approximately 38-50% of fluconazole, and a supplemental dose should be administered post-dialysis 4, 5

The National Comprehensive Cancer Network recommends careful monitoring of drug interactions in solid organ and hematopoietic stem cell transplant recipients, particularly with cyclosporine, corticosteroids, and anticonvulsants 6

The American Society of Health-System Pharmacists suggests monitoring renal function regularly, as changes necessitate dose adjustments and affect interaction severity 4
For patients on antiretroviral drugs, careful evaluation is necessary due to CYP3A4 and CYP2C9 inhibition 4

The Infectious Diseases Society of America recommends sequential therapy with micafungin followed by fluconazole step-down for candidemia after blood culture clearance and clinical stabilization 7
Fluconazole inhibits CYP3A4 and CYP2C9, creating interactions with immunosuppressants, which require monitoring of drug levels and dose adjustments, particularly in transplant recipients 8
Guidelines suggest using echinocandins, including micafungin, for initial therapy of invasive candidiasis, with step-down to fluconazole if the isolate is susceptible 7

Monitoring for fluconazole-related drug interactions with immunosuppressants is necessary, requiring therapeutic drug monitoring of calcineurin inhibitors and dose adjustments 8